Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
Is a |
Hydrocortisone-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
Is a |
Product containing hydrocortisone in otic dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
Is a |
Product containing ciprofloxacin (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ciprofloxacin hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
Is a |
Ciprofloxacin+hydrocortisone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ciprofloxacin hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|